NightWare Newsroom
Keep up with the latest news, press releases, and highlights from NightWare, Inc..
Company logo
About
NightWare, Inc. is a Minneapolis-based digital health company and developer of the only FDA-cleared prescription digital therapeutic indicated for nightmare disorder in adults with post-traumatic stress disorder (PTSD). The NightWare system pairs a wrist-worn system with a proprietary AI application to monitor sleep physiology and deliver personalized, non-awakening vibrotactile interventions that disrupt the nightmare cycle. NightWare holds De Novo 510(k) FDA clearance and Breakthrough Device Designation. The company serves patients across the VA health system, commercial, and direct-pay channels and is currently executing a national VA Pathfinder Innovation Pilot. NightWare is a prescription device. It is not a standalone therapy for PTSD and should be used in conjunction with clinician-directed care. Individual results may vary. www.nightware.com
Contact
Press Contact:
Matthew Tucker
NightWare, Inc.
8900 Excelsior Blvd
Hopkins, MN 55343
Contact email:
matthew@nightware.com
Website:
https://nightware.com/
